Biotage Announces New Methods for the Extraction of Key Compounds for Clinical, Environmental and Forensic Applications
Charlotte, North Carolina, USA, January 10, 2011 / b3c newswire / - Biotage ® (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, introduced a new series of application notes utilizing the industry-standard RapidTrace ® SPE Workstation . These methods are now available at www.biotage.com . New applications include extractions from plasma, urine and whole blood, typically assayed in clinical and forensic protocols. Additionally, a new soil analysis method for dioxins and furans joins the presently available EPH protocols from Biotage.
“By offering SPE methods ready for use on the RapidTrace, labs are better able to quickly achieve consistent solid phase extraction results that meet industry needs for low to high throughput applications” says Anna-Karin Wihlborg, Biotage Product Manager. “These new methods further strengthen our portfolio of support illustrate that Biotage is committed to providing the tools our customers need to achieve greater results.”
The RapidTrace Workstation is the gold standard for efficient and reliable solid phase extraction from low to high throughput applications. Up to 10 RapidTrace Modules can be controlled simultaneously by one computer allowing for a scalable solution.
RapidTrace users can receive free software updates with the new methods pre-loaded by contacting a Biotage Representative. The RapidTrace utilizes effortless point-and-click software allowing for simple execution of pre-loaded methods as well as easy custom method set-up and editing.
Newly Released Methods for RapidTrace:
For more information regarding the application methods and the complete line of Biotage products for sample preparation, visit www.biotage.com .
About Biotage - www.biotage.com
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. The customers include the world’s top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.
For further press information at Biotage please contact:
Rob Thompson
Director of Marketing Communications
10430 Harris Oaks Blvd., Suite C
Charlotte, NC USA 28269
Tel: +1 704 654 4847
Fax: +1 704 654 4917
Email: rob.thompson@biotage.com